Elevated expression of the chemokine-scavenging receptor D6 is associated with impaired lesion development in psoriasis
about
Atypical Chemokine Receptors and Their Roles in the Resolution of the Inflammatory ResponseRegulation of the immune and inflammatory responses by the 'atypical' chemokine receptor D6.Renal Protection by Genetic Deletion of the Atypical Chemokine Receptor ACKR2 in Diabetic OVE MiceMicroarray analyses demonstrate the involvement of type I interferons in psoriasiform pathology development in D6-deficient mice.International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors.Atypical chemokine receptor ACKR2 controls branching morphogenesis in the developing mammary gland.G protein-coupled receptors in rheumatology.Proteomics focusing on immune markers in psoriatic arthritis.Overview and potential unifying themes of the atypical chemokine receptor family.Elevated ACKR2 expression is a common feature of inflammatory arthropathies.Cytokine decoy and scavenger receptors as key regulators of immunity and inflammation.ACKR2: An Atypical Chemokine Receptor Regulating Lymphatic Biology.The N-terminal region of the atypical chemokine receptor ACKR2 is a key determinant of ligand bindingExpression of the chemokine decoy receptor D6 is decreased in colon adenocarcinomas.Spread of Psoriasiform Inflammation to Remote Tissues Is Restricted by the Atypical Chemokine Receptor ACKR2.Cell-autonomous regulation of neutrophil migration by the D6 chemokine decoy receptor.The Lymphatic System: Integral Roles in Immunity.The atypical chemokine receptor ACKR2 suppresses Th17 responses to protein autoantigens.MicroRNA-146 and cell trauma downregulate expression of the psoriasis-associated atypical chemokine receptor ACKR2.The Atypical Chemokine Receptor Ackr2 Constrains NK Cell Migratory Activity and Promotes Metastasis
P2860
Q26744960-79D1E285-F765-4448-8DA9-0867D24935F5Q34309912-29175193-6686-4408-A962-BC4F6CD52F26Q36424155-C11724AF-3354-44E9-9F2D-B46D63301EB1Q37405023-75B6018F-0BD0-46DF-8333-68EC86452401Q37432097-CB1665DF-905F-4603-A6F7-187E76B94133Q37612817-1ACF3684-5771-4EDD-AA15-F71C547D5709Q38209549-7E720619-5E25-4EB2-BFA9-FD453E5719D7Q38230695-69BA84FC-35C5-4105-BA53-4715274F86D1Q38689110-3172532E-C784-484D-A6B6-C764BAC59062Q38795628-C019C674-E71D-4B40-9A10-7C9208EF7F73Q38920969-AAA3B93A-3B0E-4801-9F59-366FE015AD09Q38998705-F1C8EBEB-0D10-42EC-BB27-F7C5D05A1FF6Q39014019-E37C56E1-7801-4870-8A19-690AF765247DQ39354015-1BECC01A-3C7F-4097-AE1D-A3F0B56C020CQ39635125-CD07EE04-19DF-4D9E-AB4F-11D2AF309860Q39882857-FDF59BFA-666A-4254-B614-B38611DA5901Q41340368-A06955A5-67C8-40EF-B7B9-0081CE853DE8Q41687121-FF16793D-9448-49DA-9FF2-C5C65E02FD3FQ47253178-88977EB5-4958-4575-A4C7-A8D172F62E62Q57464749-6A1E3AA0-63C0-491E-9971-CBEA0B489F70
P2860
Elevated expression of the chemokine-scavenging receptor D6 is associated with impaired lesion development in psoriasis
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Elevated expression of the che ...... esion development in psoriasis
@en
type
label
Elevated expression of the che ...... esion development in psoriasis
@en
prefLabel
Elevated expression of the che ...... esion development in psoriasis
@en
P2093
P2860
P50
P1476
Elevated expression of the che ...... esion development in psoriasis
@en
P2093
Anne Thorrat
David Burden
Helen Baldwin
Jose M Carballido
Kenneth Pallas
Kit Ming Lee
Mark D Singh
Ruairidh Nicoll
Susan Holmes
Thomas Jamieson
P2860
P304
P356
10.1016/J.AJPATH.2012.06.042
P407
P577
2012-08-04T00:00:00Z